Software As A Medical Device: Can It Be Patented?

3 minutes

Table of Contents

Andrew Rapacke
Andrew Rapacke is a registered patent attorney and serves as Managing Partner at The Rapacke Law Group, a full service intellectual property law firm.
Software Medical Device Patent

In general, if computer software meets the definition, software can be deemed a “medical device” by the US Food and Drug Administration (FDA) and can also be patented, though patenting software can be difficult. The standards used for patentability and what constitutes a “medical device” for the FDA are, however, different.

FDA Definition of SaMD

On December 8, 2017, the FDA issued Guidance related to software-as-medical-device (SaMD), which represents “… the current thinking” on the topic of SaMD. The Guidance specifically states that “[i]t does not establish any rights for any person and is not binding on the FDA or the public.” The Guidance adopts the “internationally converged principles agreed upon” and developed by the International Medical Device Regulators Forum (IMDRF). See, for example, this information guide issued in 2013.

Under the Guidance, SaMD is considered software that provides an “independent review” or provides “significant” information in treatment or diagnosis of a medical or health condition. Software that merely retrieves information, optimizes performance of a medical device or that organizes data is not considered SaMD. Likewise, software that is incorporated into and serves to drive particular hardware for a medical device is not considered SaMD.

In regard to the information provided, SaMD is expected to provide information that is “significant” to making a healthcare decision. Information that is “significant” includes:

  • Assessing medical condition — e.g., identification of the medical problem.
  • Assessing seriousness of medical condition — e.g., non-serious, serious, and critical.
  • Information informing treatment or diagnosis.
  • Information that drives clinical management — e.g., medication should be given at certain intervals.
  • Information that informs clinical management — e.g., now is the time for medication but not just because time has passed.

In addition to providing “significant” information, the SaMD should have a level of “independence.” That is, in general, SaMD should be capable of running on any general purpose computing platform and should, at least in theory, be able to accomplish its medical task if separated from its “normal” housing. As such, software that is necessary for medical hardware to run or that cannot be separated from the hardware is not considered SaMD.

The KardiaBand for the Apple Watch

In November of 2017, the FDA approved the first medical device accessory for the Apple Watch, the KardiaBand electrocardiogram reader. The KardiaBand replaces the original Apple watch band and combines a sensor with an artificial intelligence software application that detects abnormal heart rhythm or atrial fibrillation. The KardiaBand continually monitors the user’s heart rate to determine what is “normal” for that individual, establishing a baseline. The KardiaBand takes measurements every five seconds and will prompt the user if an abnormal reading is detected. This data can then be shared with a healthcare professional in the event of an emergency.

Without more technical information, it is difficult to determine if the KardiaBand is a “pure” software medical device or a combination device.

Taking the KardiaBand as an example, the software component of the KardiaBand should be considered SaMD if the software can perform its function on a normal computing platform and if the software can function separately from the band, even if it needs to be attached to some other sensing mechanism. The fact that SaMD might need to be interfaced with other medical hardware does not take it outside of the definitions used by the IMDRF and the FDA.

Software as Medical Device: Patentability

As noted, even though the FDA may consider certain software to be a medical device, that designation by the FDA will have little impact on the patentability of SaMD. Furthermore, patenting medical software, as software, is difficult but not impossible. With respect the SaMD, if the software is incorporated into a medical technology, it may be possible to obtain patent protection for the software as it pertains to the medical device.

Need Help Protecting the IP Associated With Your SaMD?

If you need more information about SaMD, please do not hesitate to contact an experienced and skilled attorney at The Rapacke Law Group. The professionals at RLG can be reached by calling 954-951-0154 to schedule a free initial consultation or you can fill out this online contact form.

Schedule a Free Strategy Call
  • Get help identifying what type of IP protection may the best fit for your situation.
  • We explain every step of the IP protection process
  • Get answers to your questions.

Recommended for you

Want more actionable IP tips like this delivered straight to your inbox?